Jan B. M. J. Jansen
#142,837
Most Influential Person Now
Jan B. M. J. Jansen's AcademicInfluence.com Rankings
Jan B. M. J. Jansenmedical Degrees
Medical
#2622
World Rank
#3053
Historical Rank
Public Health
#392
World Rank
#405
Historical Rank
Epidemiology
#488
World Rank
#510
Historical Rank
Download Badge
Medical
Jan B. M. J. Jansen's Degrees
- PhD Epidemiology University of Amsterdam
- Masters Public Health University of Groningen
- Bachelors Biomedical Sciences Utrecht University
Why Is Jan B. M. J. Jansen Influential?
(Suggest an Edit or Addition)Jan B. M. J. Jansen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. (2004) (868)
- Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. (1996) (785)
- Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. (2008) (624)
- Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety (1994) (421)
- DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS (1987) (274)
- Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. (1999) (258)
- Radioimmunoassay of cholecystokinin in human tissue and plasma. (1983) (246)
- A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis (2006) (229)
- Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease (2003) (218)
- Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. (2001) (211)
- Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. (1991) (177)
- Satiety effects of a physiological dose of cholecystokinin in humans. (1995) (168)
- Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. (2001) (166)
- Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. (1984) (146)
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. (1990) (145)
- Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. (1990) (144)
- Evaluation of Commercially AvailableHelicobacter pylori Serology Kits: a Review (1998) (143)
- Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans. (1995) (139)
- SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. (2005) (135)
- Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. (1999) (135)
- Fate of fructo-oligosaccharides in the human intestine (1996) (133)
- Comparison of Guaiac and Immunochemical Fecal Occult Blood ests for Colorectal Cancer in a Screening Population (129)
- Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. (1985) (129)
- Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man. (1985) (121)
- Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. (2011) (117)
- Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme (2009) (113)
- Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. (2008) (109)
- Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. (1990) (108)
- FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis (2005) (107)
- Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. (1994) (103)
- False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening (2009) (103)
- Evaluation of a Gastrointestinal Symptoms Questionnaire (2006) (101)
- 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. (2005) (94)
- Altered postprandial motility in chronic pancreatitis: role of malabsorption. (1997) (93)
- Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes. (1990) (91)
- Meta‐analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome (2007) (90)
- Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. (2005) (90)
- Satiety effects of cholecystokinin in humans. (1994) (87)
- Characterization of the reactivity pattern of murine monoclonal antibodies against wild‐type hepatitis B surface antigen to g145r and other naturally occurring “a” loop escape mutations (1999) (86)
- Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. (1989) (86)
- Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. (1984) (85)
- Polycystic liver disease is a disorder of cotranslational protein processing. (2005) (84)
- Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. (1985) (81)
- Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. (1989) (79)
- Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. (1987) (79)
- A computerized method for rapid quantification of gallbladder volume from real-time sonograms. (1985) (78)
- Glutathione and glutathione-related enzymes in decidua and placenta of controls and women with pre-eclampsia. (1999) (76)
- Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying. (1993) (76)
- Glutathione and glutathione S-transferases in Barrett's epithelium. (1993) (74)
- 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment (2003) (73)
- Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal. (1988) (72)
- Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study (2007) (71)
- Molecular forms of cholecystokinin in human plasma during infusion of bombesin. (1983) (70)
- MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION: Effect of oltipraz, α-tocopherol, β-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase (1996) (69)
- Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. (1992) (69)
- Effect of various triglycerides on plasma cholecystokinin levels in rats. (1990) (66)
- Assessment of oxidative stress in chronic pancreatitis patients. (2006) (65)
- Molecular forms of cholecystokinin in plasma from normal and gastrectomized human subjects following a fat meal (1987) (65)
- Cholecystokinin is a physiological hormonal mediator of fat‐induced inhibition of gastric emptying in man (1988) (64)
- Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. (1982) (62)
- Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. (1985) (61)
- Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans. (1996) (61)
- Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. (1990) (60)
- Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man (1993) (59)
- Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. (2004) (59)
- Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost‐effectiveness analysis (2011) (59)
- Estimating the cost of lost productivity in dyspepsia (1998) (58)
- Plasma Pancreatic Polypeptide Responses to Insulin Hypoglycaemia after Nissen Fundoplication (1989) (57)
- Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man. (1988) (57)
- Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. (1990) (56)
- Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. (1990) (55)
- The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers (1997) (55)
- Pharmacological management of pain in chronic pancreatitis. (2006) (55)
- Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids. (1996) (55)
- Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. (1989) (55)
- Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects (2004) (55)
- Effect of ageing on postprandial conjugated and unconjugated serum bile acid levels in healthy subjects (1993) (54)
- Plasma Cholecystokinin Response to Oral Fat in Patients with Billroth I and Billroth II Gastrectomy (1984) (53)
- Gastrointestinal disorders and symptoms: does body mass index matter? (2006) (52)
- Effect of truncal vagotomy on cholecystokinin release, gallbladder contraction, and gallbladder sensitivity to cholecystokinin in humans. (1990) (52)
- Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. (1995) (51)
- Medium-chain, triglyceride-containing lipid emulsions increase human neutrophil beta2 integrin expression, adhesion, and degranulation. (2000) (51)
- Functional Dyspepsia: Not All Roads Seem to Lead to Rome (2009) (49)
- Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial (2009) (49)
- Reversible gall bladder dysfunction in severe pancreatic insufficiency. (1989) (47)
- Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract. (1988) (47)
- Genetic polymorphisms in alcohol-metabolizing enzymes and chronic pancreatitis. (2004) (47)
- Diagnostic performance of biopsy-based methods for determination of Helicobacter pylori infection without a reference standard. (2000) (46)
- Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons. (1994) (45)
- Gall bladder contraction induced by cholecystokinin: bolus injection or infusion? (1986) (45)
- Antral Glutathione Concentration and Glutathione S-Transferase Activityin Patients with and WithoutHelicobacter pylori (2000) (44)
- Effects of nonsteroidal anti-inflammatory drugs on glutathione S-transferases of the rat digestive tract. (1997) (44)
- Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases (2005) (44)
- Abnormalities of upper gut motility in patients with slow-transit constipation. (1999) (44)
- Effects of somatostatin on human satiety. (1995) (43)
- Radioimmunoassay of Cholecystokinin: Production and Evaluation of Antibodies (1983) (43)
- Effect of circulating peptide YY on gallbladder emptying in humans. (2001) (42)
- Sandwich ELISA for glutathione S-transferase Alpha 1-1: plasma concentrations in controls and in patients with gastrointestinal disorders. (1996) (42)
- Gastrointestinal Symptoms are Still Prevalent and Negatively Impact Health-Related Quality of Life: A Large Cross-Sectional Population Based Study in The Netherlands (2013) (42)
- Circulating Gastrointestinal Hormone Abnormalities in Patients With Severe Idiopathic Constipation (1998) (42)
- Regulation of gastric and pancreatic lipase secretion by CCK and cholinergic mechanisms in humans. (1997) (42)
- Physiological role and localization of cholecystokinin release in dogs. (1986) (42)
- Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma. (2009) (41)
- Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism. (1993) (41)
- Radioimmunoassay of Human Pepsinogen A and Pepsinogen C (1989) (41)
- Pancreatic secretory response to intravenous caerulein and intraduodenal tryptophan studies: before and after stepwise removal of the extrinsic nerves of the pancreas in dogs. (1989) (40)
- Evidence that gastrin 34 is preferentially released from the human duodenum. (1982) (40)
- Gastrointestinal symptoms are still common in a general Western population. (2008) (39)
- Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gall bladder motility in coeliac disease. (1995) (39)
- Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. (1989) (39)
- Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer (2006) (39)
- Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency. (2006) (38)
- Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women (1995) (38)
- Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency (1989) (38)
- Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin. (2008) (37)
- Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. (2008) (37)
- Low Glutathione and Glutathione S‐Transferase Levels in Barrett's Esophagus as Compared to Normal Esophageal Epithelium (1999) (37)
- Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists. (1989) (36)
- Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. (1993) (36)
- Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects. (1995) (36)
- Effect of a Specific Cyclooxygenase-Gene Polymorphism (A-842G/C50T) on the Occurrence of Peptic Ulcer Hemorrhage (2006) (35)
- Gallbladder contraction: effects of fatty meals and cholecystokinin. (1985) (35)
- Clinical Aspects of Cholecystokinin Release and Gallbladder Contraction (1989) (35)
- Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia. (2006) (35)
- Effect of atropine and somatostatin on bombesin-stimulated plasma gastrin, cholecystokinin and pancreatic polypeptide in man (1987) (34)
- Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output. (1990) (34)
- Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests. (2009) (34)
- Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans. (1993) (34)
- Simultaneous measurement of gallbladder emptying with cholescintigraphy and US during infusion of physiologic doses of cholecystokinin: a comparison. (1989) (33)
- The importance of corpus biopsies for the determination of Helicobacter pylori infection. (2005) (33)
- Identification of NSAID Users at Risk for Gastrointestinal Complications (2010) (33)
- Human gastrin-releasing peptide: biological potency in humans (1991) (33)
- Glutathione S‐transferase mu null genotype affords protection against alcohol induced chronic pancreatitis (2003) (33)
- Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: The patient perspective (2010) (32)
- Report on the Dutch Consensus Development Meeting for Implementation and Further Development of Population Screening for Colorectal Cancer Based on FOBT (2005) (32)
- The influence of different nutrients on plasma cholecystokinin levels in the rat (1988) (32)
- Plasma Cholecystokinin Response to a Liquid Fat Meal in Vagotomized Patients (1984) (32)
- Effect of loxiglumide and atropine on erythromycin‐induced reduction in gallbladder volume in human subjects (1992) (31)
- Management in general practice of patients with persistent dyspepsia. A decision analysis. (1997) (31)
- Basal and Fat-Stimulated Plasma Peptide YY Levels in Celiac Disease (2001) (31)
- Helicobacter pylori Infection Treatment of Nonulcer Dyspepsia: An Analysis of Meta-Analyses (2003) (31)
- Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. (1993) (30)
- A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis. (2008) (30)
- Mortality trend from cancer of the gastric cardia in The Netherlands, 1969-1994. (1999) (30)
- Predominant Symptom Behavior in Patients With Persistent Dyspepsia During Treatment (2004) (30)
- Masses and pain in the groin: a review of imaging findings (1998) (30)
- Helicobacter pylori antibiotic resistance in a Dutch region: trends over time. (2006) (30)
- Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients (1989) (30)
- Glutathione S-transferases in esophageal cancer. (1993) (30)
- Serum alkaline phosphatase activity during zinc deficiency and long-term inflammatory stress. (1996) (29)
- Effect of atropine on the plasma cholecystokinin response to intraduodenal fat in man. (1984) (29)
- Meta‐analysis: the influence of pre‐treatment with a proton pump inhibitor on Helicobacter pylori eradication (2005) (29)
- Secretin injection test in the diagnosis of gastrinoma (1981) (29)
- Effects of acute hypercalcemia on exocrine pancreatic secretion in the cat. (1985) (28)
- Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission. (2007) (28)
- Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. (1983) (27)
- Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters. (1989) (27)
- The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man. (1989) (26)
- The value of methods to determine zinc deficiency in patients with Crohn's disease. (1998) (26)
- Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease (2001) (26)
- Effect of oltipraz, alpha-tocopherol, beta-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase. (1996) (26)
- Effect of bile salt binding or protease inactivation on plasma cholecystokinin and gallbladder responses to bombesin. (1994) (26)
- Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels. (1992) (26)
- Short mucin 6 alleles are associated with H pylori infection. (2006) (25)
- Effect of hyperglycaemia on gallbladder motility in Type 1 (insulin-dependent) diabetes mellitus (2004) (25)
- Effect of bombesin on plasma cholecystokinin in normal persons and gastrectomized patients measured by sequence-specific radioimmunoassays. (1984) (25)
- Gallbladder sensitivity to cholecystokinin in coeliac disease. Correlation of gallbladder contraction with plasma cholecystokinin-like immunoreactivity during infusion of cerulein. (1991) (25)
- Imaging Features of Somatostatinoma: MR, CT, US, and Angiography (1994) (25)
- Hyperglycemia modulates gallbladder motility and small intestinal transit time in man (1993) (25)
- Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis. (1998) (24)
- Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide (1991) (24)
- Serum pepsinogens in patients with gastric diseases or after gastric surgery. (1994) (24)
- Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome. (2008) (24)
- Celiac disease and geographic (serpiginous) choroidopathy with occurrence of thrombocytopenic purpura. (1983) (24)
- CT and MR Imaging of Advanced Zollinger-Ellison Syndrom (1989) (24)
- Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster. (1990) (24)
- Pancreatobiliary responses to an intragastric amino acid meal: comparison to albumin, dextrose, and a maximal cholecystokinin stimulus. (1989) (23)
- Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid. (2005) (23)
- Eradication of Helicobacter pylori Restores Glutathione S‐Transferase Activity and Glutathione Levels in Antral Mucosa (2001) (23)
- Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man (1991) (22)
- Postprandial conjugated and unconjugated serum bile acid levels after proctocolectomy with ileal pouch-anal anastomosis. (1993) (22)
- Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on small-bowel transit time in humans. (1995) (22)
- Liver function following pregnancy complicated by the HELLP syndrome (1998) (22)
- Hyperhomocysteinaemia and Vitamin B12 Deficiency: The Long-Term Effects in Cardiovascular Disease (2006) (22)
- Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis (2002) (22)
- Effect of subtotal colectomy on gastric emptying of a solid meal in slow-transit constipation (2001) (22)
- Hyperglycemia reduces gallbladder emptying and plasma hormone secretion to modified sham feeding and regular feeding (1993) (21)
- Inhibition of pancreaticobiliary secretion by loperamide in humans (1997) (21)
- Serum pancreatic polypeptide responses to food and secretion in patients with Billroth I and Billroth II gastrectomies and in normal subjects. (1982) (21)
- UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls (2008) (21)
- With medium-chain triglycerides, higher and faster oxygen radical production by stimulated polymorphonuclear leukocytes occurs. (2000) (20)
- Repeated intravenous bolus injections of omeprazole: effects on 24-hour intragastric pH, serum gastrin, and serum pepsinogen A and C. (1991) (20)
- Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia (2005) (20)
- Immune function and leukocyte sequestration under the influence of parenteral lipid emulsions in healthy humans: a placebo-controlled crossover study. (2008) (20)
- Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia (2011) (20)
- Undefined malabsorption syndrome with villous atrophy successfully reversed by treatment with cyclosporine. (1995) (20)
- Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man. (1992) (20)
- Sucrose polyester does not inhibit gastric acid secretion or stimulate cholecystokinin release in men. (1997) (19)
- ORIGINAL ARTICLES—ALIMENTARY TRACT Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial (2008) (19)
- Association of aspirin use with vitamin B12 deficiency (results of the BACH study). (2004) (19)
- Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans (1998) (19)
- Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. (1991) (18)
- Effect of Increasing Doses of Ranitidine on Exposure of the Oesophagus to Gastric Acid in Patients with Reflux Oesophagitis (1988) (18)
- Divergent Roles of SPINK1 and PRSS2 Variants in Tropical Calcific Pancreatitis (2008) (18)
- Gastrointestinal disturbances with obesity. (1993) (18)
- MR, CT, and ultrasound findings of metastatic vipoma in pancreas. (1989) (18)
- Biomarkers in Barrett's esophagus (review). (1998) (18)
- Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201-995). (1990) (18)
- Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. (1991) (17)
- Anxiety, depression and psychotropic medication use in patients with persistent upper and lower gastrointestinal symptoms (2005) (17)
- Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. (1993) (17)
- Eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia. Effects on basal and bombesin-stimulated serum gastrin and gastric acid secretion. (1995) (17)
- Open-Access Upper Gastrointestinal Endoscopy a Decade after the Introduction of Proton Pump Inhibitors and Helicobacter pylori Eradication: A Shift in Endoscopic Findings (2007) (17)
- Impaired release of peptide YY in patients with proctocolectomy and ileal pouch-anal anastomosis. (1999) (17)
- The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats (1989) (17)
- Cholecystokinin and gastrointestinal cancer (1990) (16)
- Alexithymia is Associated With Gastrointestinal Symptoms, but Does Not Predict Endoscopy Outcome in Patients With Gastrointestinal Symptoms (2006) (16)
- Low binding of Bolton-Hunter-labelled cholecystokinin-33 to carboxyl-terminal CCK-antibodies. (1982) (16)
- Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide (1990) (16)
- M1013 a Cost-Effectiveness Analysis in Colorectal Cancer Screening Comparing Immunochemical Faecal Occult Blood Tests with Guaiac Faecal Occult Blood Tests and No Screening. (2009) (16)
- Long-term omeprazole therapy does not affect Helicobacter pylori status in most patients. (1993) (16)
- Gallbladder responses to modified sham feeding: effects of the composition of a meal. (1993) (16)
- Significant satiety effect of bombesin in lean but not in obese subjects. (1994) (16)
- Functional polymorphisms of UDP-glucuronosyltransferases 1A1, 1A6 and 1A8 are not involved in chronic pancreatitis. (2004) (16)
- Gallbladder motility and cholecystokinin release during long-term enteral nutrition in patients with Crohn's disease. (1994) (16)
- Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats. (1992) (16)
- Decreased gastrin secretion in patients with late-onset hypogammaglobulinemia. (1988) (15)
- Serum trypsin, alpha-amylase and lipase during bombesin stimulation in normal subjects and patients with pancreatic insufficiency. (1984) (15)
- Role of antrum in regulation of pancreaticobiliary secretion in humans. (1996) (15)
- Getting adequate information across to colorectal cancer screening subjects can be difficult (2008) (15)
- Pharmacokinetics of budesonide-controlled ileal release capsules in active Crohn's disease (1996) (15)
- Effect of Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 (UGT1A6) on Acetylsalicylic Acid Metabolism in Healthy Female Volunteers (2009) (15)
- Effect of gastrectomy with either Roux-en-Y or Billroth II anastomosis on small-intestinal function. (1990) (15)
- Basal serum gastrin concentrations before and after eradication elicobacter pylori infection measured by sequence specific radioimmunoassays (1994) (14)
- Short-term results of gastrectomy with Roux-en-Y or Billroth II anastomosis for peptic ulcer. A prospective comparative study. (1992) (14)
- Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. (1992) (14)
- Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin. (1988) (14)
- Plasma cholecystokinin and gallbladder responses to intraduodenal fat and intravenous cholecystokinin in patients with coeliac disease (1992) (14)
- Cholecystokinin and Pancreatic Cancer (1988) (14)
- Crossover Study on Effects of Duct Obliteration, Celiac Denervation, and Autotransplantation on Glucose- and Meal-Stimulated Insulin, Glucagon, and Pancreatic Polypeptide Levels (1989) (14)
- Gastrointestinal symptoms in NSAID users in an ‘average risk population’: results of a large population‐based study in randomly selected Dutch inhabitants (2014) (14)
- Parenteral structured triglyceride emulsion improves nitrogen balance and is cleared faster from the blood in moderately catabolic patients. (2001) (14)
- Life-threatening water intoxication during somatostatin therapy. (1987) (14)
- Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis (2009) (14)
- The effect of somatostatin on bombesin-stimulated serum gastrin and gastric acid secretion in man. (1981) (14)
- Gut Hormone Profiles in Critically Ill Neonates on Extracorporeal Membrane Oxygenation (2005) (14)
- Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanism. (1993) (14)
- Delayed plasma cholecystokinin and gallbladder responses to intestinal fat in patients with Billroth I and II gastrectomy. (1989) (13)
- The influence of pretreatment on cure rates of Helicobacter pylori eradication. (2004) (13)
- Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. (1989) (13)
- Short-term follow-up by serology of patients given antibiotic treatment for Helicobacter pylori infection. (1998) (13)
- Effect of aging on plasma cholecystokinin secretion and gallbladder emptying (1988) (13)
- Similar fecal immunochemical test results in screening and referral colorectal cancer. (2012) (13)
- Vitamin B12 status and its association with Helicobacter pylori infection in alcohol dependent patients. (2004) (13)
- Long-term follow-up of empirical treatment or prompt endoscopy for patients with persistent dyspeptic symptoms? (2004) (13)
- Relationship between hunger and plasma cholecystokinin during weight reduction with a very low calorie diet. (1993) (13)
- Genetic Basis of Chronic Pancreatitis (2002) (13)
- Depression of plasma levels of cytokines and ex-vivo cytokine production in relation to the activity of the pituitary-adrenal axis, in patients undergoing major vascular surgery. (1999) (13)
- Glutathione S‐Transferases in Small Intestinal Mucosa of Patients with Coeliac Disease (2001) (13)
- Gut Hormones in Preterm Infants With Necrotizing Enterocolitis During Starvation and Reintroduction of Enteral Nutrition (2002) (13)
- Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man (2004) (12)
- Effect of cisapride on gallbladder motility after extracorporeal shock-wave lithotripsy. (1995) (12)
- SCN 9 A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels (2010) (12)
- Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin (2014) (12)
- Contribution of Partial Pancreatectomy, Systemic Hormone Delivery, and Duct Obliteration to Glucose Regulation in Canine Pancreas: Importance in Pancreas Transplantation (1989) (12)
- Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man. (1993) (12)
- Cholecystokinin and satiation. (1993) (11)
- Effect of intermittent weekend therapy with omeprazole on basal and postprandial serum gastrin concentrations in patients with duodenal ulcer (1988) (11)
- Exocrine Pancreatic Insufficiency and Pancreatic Fibrosis due to Duodenal Somatostatinoma in a Patient with Neurofibromatosis (1992) (11)
- Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans (1998) (11)
- Prospective comparison of gastric secretory function after gastrectomy with either Billroth II or Roux-en-Y anastomosis. (1989) (11)
- Gastrointestinal hormone secretion after surgery in neonates with congenital intestinal anomalies during starvation and introduction of enteral nutrition. (2003) (10)
- Nutrient-specific effects of modified sham feeding on pancreatic polypeptide release. (1994) (10)
- Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro. (1991) (10)
- Diagnostic Efficacy of the Secretin Stimulation Test for the Zollinger-Ellison Syndrome: An Intra-Individual Comparison Using Different Dosages in Patients and Controls (2010) (10)
- Plasma gastrin responses to bombesin and antral gastrin concentrations in patients with the intestinal type of gastric cancer. (1988) (10)
- The effect of a gastrin-receptor antagonist on gastric acid secretion and serum gastrin in the Zollinger-Ellison syndrome. (1983) (10)
- FDG-PET in the detection of early pancreatic cancer in a BOP hamster model. (2005) (10)
- Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting. (2004) (10)
- Plasma glutathione S-transferase alpha 1-1 levels in patients with chronic liver disorders. (1997) (10)
- Is there any association between referral indications for open-access upper gastrointestinal endoscopy and endoscopic findings? (2007) (10)
- Surgical Treatment for Pain Relief in Chronic Pancreatitis (1988) (10)
- Omeprazole as adjunct to enzyme replacement in severe pancreatic insufficiency. (1986) (10)
- Immunological evidence of cholecystokinin-39 in porcine brain. (1983) (10)
- Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. (1991) (10)
- Prevalence of gastrointestinal symptoms in alcoholics and the relationship with alexithymia (2004) (10)
- Calcitonin and secretin inhibit bombesin-stimulated serum gastrin and gastric acid secretion in man (1981) (9)
- Health‐related quality of life in patients with cardiovascular disease – the effect of upper gastrointestinal symptom treatment (2004) (9)
- The Role of Epoxide Hydrolase Y113H Gene Variant in Pancreatic Diseases (2009) (9)
- CHOLINERGIC REGULATION OF PANCREATIC POLYPEPTIDE SECRETION IN CHRONIC RENAL FAILURE (1984) (9)
- Plasma cholecystokinin levels and gallbladder volumes after proctocolectomy with ileal pouch-anal anastomosis. (1995) (9)
- Effect of increasing oral doses of loperamide on gallbladder motility in man. (1990) (9)
- Contemporary radiological examination of the small bowel. (1994) (8)
- Genetic polymorphisms in UDP-glucuronosyltransferase 1A6 are not associated with NSAIDs-related peptic ulcer haemorrhage. (2009) (8)
- Effect of short-term omeprazole administration of serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion (2004) (8)
- Cholinergic regulation of PP release is mediated through muscarinic M1-receptors. (1989) (8)
- Prospective study of the effect of gastrectomy with and without bile reflux on serum pepsinogens. (1989) (8)
- Does Intraduodenal Administration of Sucrose Polyester (Olestra) Cause Satiation in Humans? (1999) (8)
- Omeprazole as adjunct to enzyme replacement treatment in severe pancreatic insufficiency (1986) (8)
- Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis. (2011) (8)
- Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion. (1997) (8)
- Pain in chronic pancreatitis. (1995) (8)
- Inhibition of meal-stimulated gastric acid secretion by gastrin immunoneutralization in rats. (1991) (8)
- Effect of short-term administration of omeprazole on serum gastrin and pepsinogens in antrectomized patients. (1993) (8)
- Plasma Cholecystokinin, Plasma Peptide YY and Gallbladder Motility in Patients with Slow Transit Constipation: Effect of Intestinal Stimulation (2000) (8)
- The nondigestible fat sucrose polyester does not stimulate gallbladder emptying in humans. (1998) (7)
- Pancreatic morphology and function in adult patients with cystic fibrosis. (1992) (7)
- Paraoxonase 1-192Q Allele is a Risk Factor for Idiopathic Chronic Pancreatitis (2012) (7)
- Plasma glutathione S-transferase Pi 1-1 measurements in the study of hemolysis in hypertensive disorders of pregnancy. (1999) (7)
- Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man. (1990) (7)
- Gastric emptying after partial gastrectomy without vagotomy with primary Roux‐en-Y or Billroth II anastomosis (1989) (7)
- High doses of ranitidine in patients with reflux oesophagitis. (1990) (7)
- Inhibition of gastrin-stimulated gastric acid secretion by medium-chain triglycerides and long-chain triglycerides in healthy young men (1996) (7)
- Gastrointestinal Symptoms and Ethanol Metabolism in Alcoholics (2004) (7)
- Serum pepsinogen I in hereditary hypergastrinemic peptic ulcer syndromes. (1985) (6)
- [The value of CT for the diagnosis of rectal cancer recurrence. A ROC study and a retrospective analysis]. (1994) (6)
- Omeprazole in the short-term treatment of reflux oesophagitis. (1989) (6)
- Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. (2011) (6)
- Elemental diet stimulates gallbaldder contraction and secretion of cholecystokinin and pancreatic polypeptide in man (2005) (6)
- Increased plasma cholecystokinin levels and small gall bladders in adult patients with cystic fibrosis. (1991) (6)
- Gastric abnormalities in humoral immune deficiency syndromes. (1992) (6)
- Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion (1994) (6)
- Relation between gastric emptying of albumin-dextrose meals and cholecystokinin release in man (1994) (6)
- Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog. (1991) (6)
- Effects of lorglumide on gastrin- and peptone-stimulated gastric acid secretion in rats. (1990) (5)
- HYPOGAMMAGLOBULINAEMIA AND GASTRIC CANCER (1985) (5)
- The predictive value of vitamin B12 concentrations and hyperhomocysteinaemia for cardiovascular disease (2007) (5)
- [Intrathecal administration of morphine and bupivacaine in the treatment of severe pain in chronic pancreatitis]. (1996) (5)
- Empirical treatment followed by a test and treat strategy versus prompt endoscopy or radiography in patients with dyspeptic symptoms, a randomized trial in primary care setting (2001) (5)
- Recurrent idiopathic pancreatitis in familial adenomatous polyposis: Report of a case-series and review of the literature (2007) (5)
- The in-vitro uptake of zinc by blood cells in rats with long-term inflammatory stress. (1994) (5)
- Open Access Capture of Patients With Gastroesophageal Reflux Disease Using an Online Patient-Reported Outcomes Instrument (2012) (5)
- and development of atrophic gastritis during omeprazole maintenance therapy (1995) (5)
- Short-Term Follow-Up by Serology of Patients Given Antibiotic Treatment for Helicobacter pyloriInfection (1998) (5)
- Effect of erythromycin on pancreatic polypeptide release: role of the vagal nerve. (1994) (5)
- Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers. (1990) (5)
- Effects of Helicobacter pylori infection on endocrine and exocrine mucosal functions in the upper gastrointestinal tract. (2000) (5)
- Peptide YY release after colectomy in slow transit constipation (2004) (5)
- Effects of somatostatin and loxiglumide on gallbladder motility (2004) (5)
- Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans (1994) (5)
- Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids (1990) (5)
- Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment (1992) (5)
- Gastrin cell function in familial multiple endocrine neoplasia type I. (1988) (5)
- Physiological concentrations of lipid emulsions and leukocyte function (1994) (4)
- Effect of immunoneutralisation of cholecystokinin on bombesin-stimulated pancreatic enzyme secretion in the rat (1989) (4)
- Role of circulating peptide YY in the inhibition of gastric acid secretion by dietary fat in humans. (2000) (4)
- Effect of medium-chain triglycerides and long-chain triglycerides on plasma pancreatic polypeptide secretion in man (1985) (4)
- A decade of experiences with radioimmunoassays for cholecystokinin in The Netherlands. (1992) (4)
- What is the preferred dose of lansoprazole in the maintenance therapy of reflux oesophagitis? The results of a Dutch multi‐center comparative trial (1998) (4)
- Characterization of antisera to cholecystokinin by use of different cholecystokinin labels. (1984) (4)
- [From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II]. (2002) (4)
- Function and survival of intrasplenic islet autografts in dogs (2004) (4)
- Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man (1993) (4)
- CT and MR imaging of advanced Zollinger-Ellison syndrome. (1989) (4)
- The role of cholecystokinin in appetite controle (1995) (4)
- Plasma Cholecystokinin and Gallbladder Responses to Increasing Doses of Bombesin in Celiac Disease (1998) (4)
- Pancreatic Secretory Response to Intrajejunal Tryptophan: Studies in Dogs with an Autotransplanted Entire Jejunoileum (1997) (4)
- Effect of circulating peptide YY on gallbladder motility in response to feeding in humans (2001) (4)
- What is the preferred dose of lansoprazole in the maintenance therapy of reflux oesophagitis? The results of a Dutch multi-center comparative trial (1998) (3)
- Contribution of gastrin to cysteamine-induced gastric acid secretion in rats. (1993) (3)
- Evidence against autocrine feedback regulation of cholecystokinin secretion in man (1992) (3)
- Mutational Analysis of the Gene Encoding the Zymogen Granule Membrane Glycoprotein 2 (GP2) in Patients With Chronic Pancreatitis (2010) (3)
- The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500. (1984) (3)
- The role of cholecystokinin in appetite control. (1995) (3)
- [From gene to disease; hepatocystin and autosomal dominant polycystic liver disease]. (2003) (3)
- Serum gastrin responses to bombesin and food in patients with hypergastrinemia (1982) (3)
- Long-term follow-up after successful eradication of with 1 or 2 weeks of quadruple therapy (1996) (3)
- Patient adherence to prescribed medication instructions for dyspepsia: The DIAMOND-study (2012) (3)
- Cholecystokinin-Receptor Antagonists in Experimental Pancreatic Tumor Growth (1991) (3)
- Role of cholecystokinin in the regulation of pancreatic enzyme secretion in the rat. (1990) (2)
- Diagnostic performance of biopsy-based methods for detection of Helicobacter pylori infection in routine clinical care (1998) (2)
- Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs (1990) (2)
- Cytokine Induction in Experimental and Ulcerative Colitis (1992) (2)
- [Rectal endosonography for perirectal and non-tumor rectal changes]. (1993) (2)
- Abnormalities of plasma cholecystokinin and peptide YY in patients with slow transit constipation (1997) (2)
- Gallbladder motility and CCK release during intermittent and continuous administration of SMS201-995 in acromegalics (1991) (2)
- Antidepressants and Gastrointestinal Symptoms in the General Dutch Adult Population (2014) (2)
- Does smoking influence the pharmacokinetics and pharmacodynamics of the H2-receptor antagonist famotidine? (1992) (2)
- Hormonal manipulation of gastrointestinal cancer by gut peptides (1988) (2)
- Gallbladder sensitivity to CCK in duodenal ulcer disease, highly selective and truncal vagotomy. (1996) (2)
- Monitoring Helicobacter pylori Eradication Therapy (1998) (2)
- The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. (2007) (2)
- Pancreatic polypeptide response to insulin induced hypoglycaemia in Parkinsonʼs disease (1999) (2)
- [Dutch patients with hereditary pancreatitis; high mutation frequency, relatively little pain]. (2009) (2)
- Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs—Reply (2005) (2)
- A comparative study of gastrectomy without vagotomy with either Roux-en-Y or Billroth II anastomosis in peptic ulcer. (1994) (2)
- Quality of Life implications in patients with cardiovascular disease and dyspeptic symptoms. (2002) (2)
- Effect of Omeprazole on Serum Gastrin and Pepsinogens after Gastric Resection (1989) (2)
- [Low prevalence of metronidazole- and clarithomycin-resistant Helicobacter pylori in the 's-Hertogenbosch region, 1998-2003]. (2005) (2)
- Reduced Diffusion in Liver Cirrhosis is Related to Impairment of Protein Liver Synthesis (2002) (2)
- T is associated with severe dyspepsia (2011) (2)
- CHOLECYSTOKININ AND CYSTIC FIBROSIS (1985) (2)
- Reproducibility of ambulatory intragastric pH monitoring. (1993) (2)
- The effect of healing of corpus gastritis on the occurrence of reflux oesophagitis and Barrett's oesophagus (2002) (2)
- Effect of Bombesin and Cholecystokinin on Plasma Immunoreactive Trypsin in Humans (1987) (2)
- Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacterpylori infection (1)
- [Screening for colorectal cancer: definitely implement]. (2008) (1)
- Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms, a randomised clinical trial (2003) (1)
- Effect of Intravenous Omeprazole on Intragastric pH during Intravenous Amino Acid Infusion (1989) (1)
- Endocrine Function after Duodenum-Preserving Resection of the Head of the Pancreas With or Without Segmental Pancreatic Autotransplantation: An Experimental Study in Dogs (1990) (1)
- Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemia (1994) (1)
- FDG-PET as a clinical tool in differentiation between pancreatic carcinoma and chronic pancreatitis (2003) (1)
- Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders. (1991) (1)
- 619 Randomized Study Comparing the Test Performance of a Guaiac-Based Fecal Occult Blood Test with An Immunochemical Fecal Occult Blood Test for Colorectal Cancer Screening in a Screening Population (2008) (1)
- 485 Gastrointestinal Symptoms are Increased in Both Prescribed and Over-the-Counter NSAID Users Compared to Non Users in the Community (2012) (1)
- S1125 Differences in Fit Results Between Screening and Referred Colorectal Cancer Patients are Explained by Differences in Tissue Tumor Stage (2010) (1)
- Effect of equimolar amounts of long chain triglycerides and medium chain triglycerides on small intestinal transit (1993) (1)
- S1117 Quantitative Immunochemical Fecal Occult Blood Screening Under a Colonoscopy Constraint: A Higher Cut-off Level, a Smaller Age Range or a Longer Screening Interval? A Cost-Effectiveness Analysis (2010) (1)
- Endocrine function of the pancreas after transplantation: the contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation by the canine pancreas. (1990) (1)
- Long-term effect of the Belsey-Mark IV anti-reflux operation on symptoms and esophagitis, in relation to post-operative manometry and 24-h pH profile. (1994) (1)
- Pancreatic enzyme secretion and plasma CCK release in response to an intraduodenal amino acid meal with and without cholestyramine (1995) (1)
- Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia (2009) (1)
- Postprandial release of cholecystokinin after duodenum-preserving total pancreatectomy is independent of intraluminal pancreatic protease activity in dogs. (1990) (1)
- LCT/MCT-(Lipofundin(r)) and pure MCT-, but not LCT-(Intralipid®) or structured Fat Emulsion 73403®, induce oxygen radical formation and potentiate the zymosan‐induced increase in cytosolic Ca2+ in human neutrophils in a protein kinase C‐dependent manner (1998) (1)
- GASTROINTESTINAL SYMPTOMS IN LOW-DOSE ASPIRIN USERS IN THE COMMUNITY: A COMPARISON BETWEEN PLAIN AND BUFFERED ASPIRIN (2010) (1)
- Vitamin B12 deficiency in patients with upper gastrointestinal symptoms in the Mekong Delta, Vietnam. (2006) (1)
- Cholecystokinin, Cholecystokinin-Receptor Antagonists and the Sphincter of Oddi (1991) (1)
- The prognostic value of gastrointestinal morbidity for gastric cancer. (1999) (1)
- Energy intake and energy expenditure in patients on home parenteral nutrition (1996) (1)
- Ratio between large and small carboxy-terminal molecular forms of cholecystokinin in brains of different species (1986) (1)
- A specific and sensitive radioimmunoassay for cholecystokinin-39 (CCK-39): Immunological evidence of CCK-39 in brain and gut (1983) (1)
- Serum pepsinogen I in familial multiple endocrine neoplasia type I (1988) (1)
- A prospective study of effects of belsey MK IV antireflux surgery on endoscopic esophagitis, lower esophageal sphincter pressure, and 24-Hr pH measurements (1994) (1)
- [Nationwide colorectal cancer screening]. (2010) (1)
- History of dyspepsia in patients with gastric cancer (1998) (1)
- Cholestyramine augments pancreatic enzyme secretion, gall-bladder contraction, plasma cholecystokinin and pancreatic polypeptide release in response to intraduodenal amino acids (1995) (1)
- Effect of loperamide on basal and amino-acid-stimulated plasma cholecystokinin release, gallbladder motility and pancreatic enzyme secretion. (1995) (1)
- Sucrose polyester fails to induce gallbladder contraction and release of plasma cholecystokinin in humans (1998) (0)
- Decreased neutrophil oxygen radical production in patients treated with D2E7, a new human anti‐TNFα monoclonal antibody (1998) (0)
- Comparative study of the effects of modified sham feeding of fat, protein and starch on gallbladder contraction and plasma cholecystokinin in man (1992) (0)
- FDG-PET detects clinical relevant adenomas of the colon: a prospective study of 100 patients. (2006) (0)
- The time trend of changing dyspeptic symptoms in patients with persistent dyspeptic symptoms during treatment (2001) (0)
- Evaluation of endoscopy outcomes a decade after nationwide introduction of protonpump inhibitors and guidelines for Helicobacter pylori eradication (2006) (0)
- Effect of a physiologic dose of cholecystokinin on food intake and satiation in man (1992) (0)
- Effect of intraduodenal long-chain triglycerides and medium-chain triglycerides on PYY-release. (1996) (0)
- Influence of lipid emulsions on polymorphonuclear leukocyte function. (1994) (0)
- Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study (2018) (0)
- Effects of a structured medication review by geriatrician and clinical pharmacologist on appropriateness of pharmacotherapy of frail elderly inpatients (2002) (0)
- [Serous otitis media viewed from 2 angles]. (1977) (0)
- [The effect of intestinal hormones on gastrointestinal carcinoma]. (1988) (0)
- [From gene to disease; hereditary pancreatitis]. (2000) (0)
- Binding characteristics of a panel of monoclonal antibodies against wild type HBsAg with G145R and other determinant escape mutants and variants (1999) (0)
- Cost effectiveness of treatment for gastro-oesophageal reflux (1998) (0)
- Factors Determining Endotoxin Sensitivity (1992) (0)
- Effect of rectal distension on meal-stimulated gallbladder motility and peptide YY release in humans (1998) (0)
- 713 False Negative Immunochemical Faecal Occult Blood Tests Due to Delayed Sample Return in Colorectal Cancer Screening. (2009) (0)
- Tumour necrosis factor alpha antibody affects gastrin release in Crohn disease. (2003) (0)
- Incubation in Lipofundin® stimulates the early respiratory burst of human neutrophils compared to Intralipid® and structured fat emulsion 73403® (1998) (0)
- Effect of food on budesonide pharmacokinetics in patients with active Crohnʼs disease (1998) (0)
- Severely impaired postprandial gallbladder emptying despite unchanged cholecystokinin release in the early phase of biliary colic. (1991) (0)
- The effect of intravenous amino acids on intragastric pH during continuous intragastric pH-monitoring. (1990) (0)
- Is circulating cholecystokinin involved in the inhibition of gastrin-stimulated gastric acid secretion by intraduodenal long-chain triglycerides and medium-chain triglycerides? (1995) (0)
- INCREASED CYSTEINE LEVEL IS ASSOCIATED WITH RECURRENT ATHEROTHROMBOTIC EVENTS AFTER ACUTE CORONARY SYNDROMES (2010) (0)
- Gastric emptying in patients with slow transit constipation before and after total abdominal colectomy (1999) (0)
- Secretin injection test in the diagnosis of gastrinoma. (1981) (0)
- No association between referral indications for open access upper GI endoscopy and endoscopic findings (2006) (0)
- Lipofundin® increases in vitro adhesion molecule expression, degranulation and binding capacity of human neutrophils, contrary to Intralipid® and structured Fat Emulsion 73403® (1998) (0)
- Effect of calcitonin (CT) and secretin (S) on bombesin (BBS)-stimulated serum gastrin and gastric acid in man (1980) (0)
- The influence of various lipid emulsions on polymorphonuclear leukocyte function (1993) (0)
- Glutathione andglutathione S-transferases inBarrett's epithelium (1993) (0)
- Serum gastrin response to bombesin (BBS) and food in the diagnosis of retained antrum (RA) after antrectomy (1980) (0)
- Implementation of colorectal cancer screening. (2006) (0)
- Molecular and clinical aspects of chronic pancreatitis (2001) (0)
- Attenuation of the gastric acid and serum gastrin – lowering effects of the prostaglandin E2 analog enprostil (1993) (0)
- Family history and survival in patients with stage III colorectal cancer. (2008) (0)
- Serum bile acids, plasma cholecystokinin (CCK), and gallbladder motility after ileal resection (IR) (1995) (0)
- Short Report Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test (2008) (0)
- Effect of intraduodenal digestible and non-digestible fat on gastrin-stimulated gastric acid secretion. (1995) (0)
- With medium-chain triglycedideds, higher and faster oxygen radical production by stimulated (2000) (0)
- Plasma cholecystokinin, plasma peptide YY and gallbladder motility after subtotal colectomy in patients with slow transit constipation (1999) (0)
- Effect of rectal distension on meal stimulated gallbladder motility and peptide YY release in humans (1998) (0)
- S1043 Gender Differences in Upper Gastrointestinal Symptom Presentation (2008) (0)
- Immunologisch effect van vet-emulsies in parenterale voeding. (1995) (0)
- Su1642 Over a Quarter of the General Adult Population Experiences Gastrointestinal Symptoms Influencing Health-Related Quality of Life: Results of 50,000 Questionnaires (2012) (0)
- [Colorectal cancer screening: immunological test for faecal occult blood preferred]. (2009) (0)
- Screening for malnutrition by nurses (1999) (0)
- Loss of range of vision and ulcerative colitis (1998) (0)
- [Drug treatment of reflux esophagitis: effects of strong gastric acid inhibition]. (1989) (0)
- Effect of food on budesonide pharmacokinetics in patients with active Crohn's disease (1998) (0)
- Moleculaire en klinische aspecten van chronische pancreatitis (2001) (0)
- Disease management of patients with persistent dyspepsia (1997) (0)
- Mo1084 Highly Persistent Partial Responsiveness in PPI Users: Results of 24-Week Follow-up Using Internet Surveys (2012) (0)
- The relation between nutritional status, diagnosis and complications at a ward for gastrointestinal diseases and internal medicine during hospital stay (1996) (0)
- S1132 Accept or Decline Fecal Occult Blood Screening for Colorectal Cancer: the Participants View (2008) (0)
- Impaired hepatocellular integrity in pre-eclampsia as assessed by measurement of plasma glutathione -transferase-alpha (1995) (0)
- Influence of medium-chain and structured triglycerides on the mononuclear phagocyte system in postoperative patients (1995) (0)
- Native low density lipoprotein induces transition of monocytic cell lines into foam cell-like cell lines (1995) (0)
- The effect of corpus gastritis healing on the occurrence of reflux oesophagitis (2000) (0)
- A germline mutation in hepatocystin underlies autosomal dominant polycystic liver disease (2003) (0)
- Effect of intraduodenal fat and non-absorbable fat on gastrin-stimulated gastric acid secretion (1995) (0)
- Plasma peptide YY responses to intraduodenal long-chain triglycerides and medium-chain triglycerides in humans. (1997) (0)
- Abnormalities of antroduodenal motility in patients with slow transit constipation (1998) (0)
- Different effects of medium-chain triglycerides and long-chain triglycerides on gastrin stimulated gastric acid secretion. (1995) (0)
- Polycystic liver disease is associated with PRKCSH and SEC63 mutations. (2006) (0)
- The effect of duodenumpreserving resection of the head of the pancreas on basal and stimulated insulin, glucagon, pancreatic polypeptide, and cholecystokinin levels in dogs (1990) (0)
- Expression of recombinant hepatitis C virus structural proteins in a baculovirus‐insect cell and mammalian cell system (1998) (0)
- T1095 Implementation of Colorectal Cancer Screening in the Netherlands: Results of the First 20,000 Pilot Study (2008) (0)
- Effect of cisapride on gallbladder motility after extracorporeal lithotripsy shock-wave (1995) (0)
- Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia. Commentary (2006) (0)
- Effects of eradicating H. pylori on symptoms in non-ulcer dyspepsia patients (1996) (0)
- Recurrent acute pancreatitis (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jan B. M. J. Jansen?
Jan B. M. J. Jansen is affiliated with the following schools:
